ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Return 169.78%
This Quarter Return
-7.92%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$127M
AUM Growth
-$132M
Cap. Flow
-$96.3M
Cap. Flow %
-75.74%
Top 10 Hldgs %
72.27%
Holding
39
New
11
Increased
5
Reduced
12
Closed
8

Top Buys

1
BLU
BELLUS Health Inc.
BLU
+$5.02M
2
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$3.61M
3
KPTI icon
Karyopharm Therapeutics
KPTI
+$2.29M
4
CRSP icon
CRISPR Therapeutics
CRSP
+$2.25M
5
AXSM icon
Axsome Therapeutics
AXSM
+$1.72M

Top Sells

1
IOVA icon
Iovance Biotherapeutics
IOVA
+$30.9M
2
ADVM icon
Adverum Biotechnologies
ADVM
+$14.1M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$11.2M
4
ATNX
Athenex, Inc. Common Stock
ATNX
+$9.36M
5
VCYT icon
Veracyte
VCYT
+$8.86M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
FOLD icon
26
Amicus Therapeutics
FOLD
$2.46B
$1.12M 0.81%
140,000
-210,000
-60% -$1.68M
APLT icon
27
Applied Therapeutics
APLT
$63.4M
$912K 0.66%
+83,000
New +$912K
KALV icon
28
KalVista Pharmaceuticals
KALV
$803M
$290K 0.21%
25,000
-188,000
-88% -$2.18M
VIRX
29
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$288K 0.21%
+11,429
New +$288K
CEMI
30
DELISTED
Chembio diagnostics, Inc.
CEMI
$255K 0.18%
41,667
– –
ADVM icon
31
Adverum Biotechnologies
ADVM
$74.3M
– –
-119,000
Closed -$14.1M
DHR icon
32
Danaher
DHR
$142B
– –
-12,972
Closed -$1.64M
XBI icon
33
SPDR S&P Biotech ETF
XBI
$5.33B
– –
0
– –
CMRX
34
DELISTED
Chimerix, Inc.
CMRX
– –
-280,000
Closed -$1.21M
VRAY
35
DELISTED
ViewRay, Inc.
VRAY
– –
-842,500
Closed -$7.42M
ATNX
36
DELISTED
Athenex, Inc. Common Stock
ATNX
– –
-23,625
Closed -$9.36M
DRNA
37
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-384,500
Closed -$6.06M
IMMU
38
DELISTED
Immunomedics Inc
IMMU
– –
-225,000
Closed -$3.12M
BHVN
39
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-255,000
Closed -$11.2M
1
2